Paradigm Biocapital Advisors LP CYTK Holdings History
Paradigm Biocapital Advisors LP's Cytokinetics Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 858,664.00 shares of Cytokinetics Inc(CYTK), totaling $34.51 Mil. This investment constitutes 1.58% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 0.72% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2025Q1. And since then Paradigm Biocapital Advisors LP has made 1 purchases of CYTK, at an average price of $45.96, for a total of 858,664.00 shares. Based on historical transaction data and CYTK's current price of $37.95, Paradigm Biocapital Advisors LP's estimated gain on his CYTK holdings is $-6.88 Mil, reflecting a -17.43% gain to date.
Paradigm Biocapital Advisors LP CYTK ($37.95) Holding Chart
Paradigm Biocapital Advisors LP CYTK ($37.95) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
